Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan T Jones

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|September 21, 2006
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA bindingDylan T Jones, Adrian L Harris
Expert Opinion on Therapeutic Targets|April 20, 2012
Small-molecule inhibitors of the HIF pathway and synthetic lethal interactionsDylan T Jones, Adrian L Harris
Cancer Research|March 3, 2006
Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbateDylan T Jones, Ian S Trowbridge, Adrian L Harris
Hippocampus|December 30, 2016
Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer's diseaseAlexandra J Mably, Brian J Gereke, Dylan T Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradationDylan T Jones, Christopher W Pugh, Simon Wigfield, et al.
Disease Models & Mechanisms|November 3, 2012
Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in miceDylan T Jones, Tanguy Lechertier, Louise E Reynolds, et al.
Nature Protocols|December 24, 2011
Use of the mouse aortic ring assay to study angiogenesisMarianne Baker, Stephen D Robinson, Tanguy Lechertier, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 25, 2022
Expression Profile of Myoepithelial Cells in DCIS: Do They Change From Protective Angels to Wicked Witches?Marwa M Dawoud, Dylan T Jones, Claude Chelala, et al.
British Journal of Haematology|June 5, 2003
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligandDylan T Jones, Kanagasabai Ganeshaguru, Wayne A Mitchell, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|September 21, 2006
Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA bindingDylan T Jones, Adrian L Harris
Expert Opinion on Therapeutic Targets|April 20, 2012
Small-molecule inhibitors of the HIF pathway and synthetic lethal interactionsDylan T Jones, Adrian L Harris
Cancer Research|March 3, 2006
Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbateDylan T Jones, Ian S Trowbridge, Adrian L Harris
Hippocampus|December 30, 2016
Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer's diseaseAlexandra J Mably, Brian J Gereke, Dylan T Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Novel thioredoxin inhibitors paradoxically increase hypoxia-inducible factor-alpha expression but decrease functional transcriptional activity, DNA binding, and degradationDylan T Jones, Christopher W Pugh, Simon Wigfield, et al.
Disease Models & Mechanisms|November 3, 2012
Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in miceDylan T Jones, Tanguy Lechertier, Louise E Reynolds, et al.
Nature Protocols|December 24, 2011
Use of the mouse aortic ring assay to study angiogenesisMarianne Baker, Stephen D Robinson, Tanguy Lechertier, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 25, 2022
Expression Profile of Myoepithelial Cells in DCIS: Do They Change From Protective Angels to Wicked Witches?Marwa M Dawoud, Dylan T Jones, Claude Chelala, et al.
British Journal of Haematology|June 5, 2003
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligandDylan T Jones, Kanagasabai Ganeshaguru, Wayne A Mitchell, et al.
Blood|October 25, 2003
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugsDylan T Jones, Elena Addison, Janet M North, et al.
Pageof 3